Annual CFF
$24.68 M
+$17.44 M+240.89%
31 December 2023
Summary:
Forte Biosciences annual cash flow from financing activities is currently $24.68 million, with the most recent change of +$17.44 million (+240.89%) on 31 December 2023. During the last 3 years, it has fallen by -$41.98 million (-62.97%). FBRX annual CFF is now -62.97% below its all-time high of $66.67 million, reached on 31 December 2020.FBRX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$2000.00
+$8000.00+80.00%
30 September 2024
Summary:
Forte Biosciences quarterly cash flow from financing activities is currently -$2000.00, with the most recent change of +$8000.00 (+80.00%) on 30 September 2024. Over the past year, it has dropped by -$24.78 million (-100.01%). FBRX quarterly CFF is now -100.00% below its all-time high of $42.39 million, reached on 31 December 2020.FBRX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$95.00 K
-$24.78 M-100.38%
30 September 2024
Summary:
Forte Biosciences TTM cash flow from financing activities is currently -$95.00 thousand, with the most recent change of -$24.78 million (-100.38%) on 30 September 2024. Over the past year, it has dropped by -$24.80 million (-100.38%). FBRX TTM CFF is now -100.14% below its all-time high of $66.67 million, reached on 31 December 2020.FBRX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FBRX Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +240.9% | -100.0% | -100.4% |
| 3 y3 years | -63.0% | +33.3% | -100.2% |
| 5 y5 years | - | - | - |
FBRX Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -63.0% | >+9999.0% | -100.0% | +98.2% | -100.2% | +48.9% |
| 5 y | 5 years | -63.0% | >+9999.0% | -100.0% | +98.2% | -100.1% | +48.9% |
| alltime | all time | -63.0% | >+9999.0% | -100.0% | +98.2% | -100.1% | +48.9% |
Forte Biosciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2000.00(-80.0%) | -$95.00 K(-100.4%) |
| June 2024 | - | -$10.00 K(+25.0%) | $24.68 M(+0.1%) |
| Mar 2024 | - | -$8000.00(-89.3%) | $24.67 M(-0.1%) |
| Dec 2023 | $24.68 M(+240.9%) | -$75.00 K(-100.3%) | $24.68 M(-0.1%) |
| Sept 2023 | - | $24.78 M(<-9900.0%) | $24.70 M(+235.3%) |
| June 2023 | - | -$24.00 K(-500.0%) | $7.37 M(+1.2%) |
| Mar 2023 | - | $6000.00(-110.9%) | $7.28 M(+0.6%) |
| Dec 2022 | $7.24 M | -$55.00 K(-100.7%) | $7.24 M(-0.2%) |
| Sept 2022 | - | $7.44 M(-6863.6%) | $7.26 M(-4001.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$110.00 K(+223.5%) | -$186.00 K(+77.1%) |
| Mar 2022 | - | -$34.00 K(-12.8%) | -$105.00 K(+138.6%) |
| Dec 2021 | -$44.00 K(-100.1%) | -$39.00 K(+1200.0%) | -$44.00 K(-100.1%) |
| Sept 2021 | - | -$3000.00(-89.7%) | $42.39 M(-0.4%) |
| June 2021 | - | -$29.00 K(-207.4%) | $42.56 M(-36.1%) |
| Mar 2021 | - | $27.00 K(-99.9%) | $66.65 M(-0.0%) |
| Dec 2020 | $66.67 M | $42.39 M(>+9900.0%) | $66.67 M(+174.6%) |
| Sept 2020 | - | $166.00 K(-99.3%) | $24.27 M(+0.7%) |
| June 2020 | - | $24.06 M(>+9900.0%) | $24.11 M(>+9900.0%) |
| Mar 2020 | - | $45.00 K | $45.00 K |
FAQ
- What is Forte Biosciences annual cash flow from financing activities?
- What is the all time high annual CFF for Forte Biosciences?
- What is Forte Biosciences annual CFF year-on-year change?
- What is Forte Biosciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Forte Biosciences?
- What is Forte Biosciences quarterly CFF year-on-year change?
- What is Forte Biosciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Forte Biosciences?
- What is Forte Biosciences TTM CFF year-on-year change?
What is Forte Biosciences annual cash flow from financing activities?
The current annual CFF of FBRX is $24.68 M
What is the all time high annual CFF for Forte Biosciences?
Forte Biosciences all-time high annual cash flow from financing activities is $66.67 M
What is Forte Biosciences annual CFF year-on-year change?
Over the past year, FBRX annual cash flow from financing activities has changed by +$17.44 M (+240.89%)
What is Forte Biosciences quarterly cash flow from financing activities?
The current quarterly CFF of FBRX is -$2000.00
What is the all time high quarterly CFF for Forte Biosciences?
Forte Biosciences all-time high quarterly cash flow from financing activities is $42.39 M
What is Forte Biosciences quarterly CFF year-on-year change?
Over the past year, FBRX quarterly cash flow from financing activities has changed by -$24.78 M (-100.01%)
What is Forte Biosciences TTM cash flow from financing activities?
The current TTM CFF of FBRX is -$95.00 K
What is the all time high TTM CFF for Forte Biosciences?
Forte Biosciences all-time high TTM cash flow from financing activities is $66.67 M
What is Forte Biosciences TTM CFF year-on-year change?
Over the past year, FBRX TTM cash flow from financing activities has changed by -$24.80 M (-100.38%)